Do food antigens in the gut drive type 2 (eosinophilic) inflammation and sometimes raise blood eosinophils?

Food antigen-driven immune activation in the gastrointestinal tract is a primary mechanism for developing Type 2 (Th2) inflammation, a process where dietary proteins act as persistent triggers for localized and, occasionally, systemic immune responses.

Clinical and Mechanistic Evidence

The relationship between food antigens and gut inflammation is most clearly demonstrated in Eosinophilic Gastrointestinal Disorders (EGIDs). In Eosinophilic Esophagitis (EoE), dietary proteins from milk, wheat, and soy are the dominant drivers of mucosal damage; clinical trials show that 70% to 90% of patients achieve histological remission through targeted dietary elimination.

Mechanistically, this process involves:

• Antigen Presentation: Food antigens bypass the epithelial barrier and are processed by dendritic cells, which promote the differentiation of Th2-type helper T cells.
• Cytokine Signaling: These Th2 cells produce a specific cytokine profile, primarily IL-4, IL-5, and IL-13. IL-5 is the critical regulator for the maturation and survival of eosinophils, while eotaxin-3 (CCL26) mediates their migration from the circulation into the gut tissue.
• Tissue Infiltration: This signaling results in dense eosinophilic infiltration, often exceeding 15 eosinophils per high-power field (HPF), which causes tissue remodeling and dysfunction.

Systemic Reflection

While the inflammation is primarily localized to the gut mucosa, it can manifest systemically as peripheral blood eosinophilia.

• Prevalence: Elevated blood eosinophils are observed in approximately 50% to 70% of patients with Eosinophilic Gastritis or Colitis, though they are less frequent in EoE (roughly 35%).
• Diagnostic Value: Although peripheral eosinophilia lacks the sensitivity to serve as a standalone diagnostic tool, its presence increases the diagnostic yield of gastrointestinal biopsies by up to 9-fold in symptomatic patients.

Bottom line

Food antigens are established drivers of Th2-mediated gut inflammation. While tissue biopsy remains the gold standard for diagnosis, elevated blood eosinophils often serve as a measurable, albeit inconsistent, systemic marker of this localized immune activation.